martes, 13 de octubre de 2026

Frontiers in Modern Oncology: Molecular-Guided Strategies for HR-Positive/HER2-Negative Metastatic Breast Cancer Authors: Giuseppe Curigliano, MD, PhD; Nicola Fusco, M

https://www.medscape.org/viewarticle/frontiers-modern-oncology-molecular-guided-strategies-hr-2026a10010ph?page=1

No hay comentarios:

Publicar un comentario